KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2025)

QuidelOrtho's Liabilities and Shareholders Equity history spans 4 years, with the latest figure at $5.7 billion for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 16.56% year-over-year to $5.7 billion; the TTM value through Dec 2025 reached $12.1 billion, down 39.51%, while the annual FY2024 figure was $6.4 billion, 24.99% down from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $5.7 billion at QuidelOrtho, down from $6.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $8.9 billion in Q1 2023 and bottomed at $2.4 billion in Q1 2022.
  • The 4-year median for Liabilities and Shareholders Equity is $6.8 billion (2024), against an average of $7.1 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 264.38% in 2023 before it decreased 24.99% in 2024.
  • A 4-year view of Liabilities and Shareholders Equity shows it stood at $8.7 billion in 2022, then dropped by 1.07% to $8.6 billion in 2023, then decreased by 24.99% to $6.4 billion in 2024, then decreased by 11.65% to $5.7 billion in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Liabilities and Shareholders Equity are $5.7 billion (Q3 2025), $6.4 billion (Q2 2025), and $6.4 billion (Q4 2024).